glp-1+gip Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic

Nowak K, Eldredge-Hindy H, Champ CE

Going against the grains: gluten-free diets in patients without celiac diseaseworthwhile or not

Using the mouse anti-GIPR antibody 2.63.1, researchers found that the antibody not only antagonized the insulin secretion induced by GIP but also exhibited a certain effect on weight reduction

The results suggest that, with proper supervision, a protein-rich diet, regular resistance training, and guidance from a trained medical provider, patients can decrease fat mass while minimizing muscle loss. We found that, under close supervision and regular follow-up from an obesity medicine specialist, patients were able to lose fat mass with only a minimal decline in muscle mass, Peralta-Reich added

In contrast, the brand-name GLP-1s are made with a semaglutide base

Many patients report better medication adherence with daily tablets compared to weekly injections, leading to more consistent weight-loss results over time